Healthcare provider profile · identity verified

Sandra Shi, MD

Internal Medicine · ROSLINDALE, MA · NPI 1023421088

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	566	39
Levothyroxine Sodium	Levothyroxine Sodium	502	26
Omeprazole	Omeprazole	413	28
Sertraline Hcl	Sertraline Hcl	363	20
Eliquis	Apixaban	322	27
Losartan Potassium	Losartan Potassium	283	20
Pravastatin Sodium	Pravastatin Sodium	269	18
Quetiapine Fumarate	Quetiapine Fumarate	260	12
Amlodipine Besylate	Amlodipine Besylate	259	23
Gabapentin	Gabapentin	237	16
Atorvastatin Calcium	Atorvastatin Calcium	230	18
Metoprolol Succinate	Metoprolol Succinate	227	16
Donepezil Hcl	Donepezil Hcl	223	12
Lorazepam	Lorazepam	194	21
Mirtazapine	Mirtazapine	183	12
Metformin Hcl	Metformin Hcl	168	13
Divalproex Sodium	Divalproex Sodium	150	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	150	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	139	suppressed
Memantine Hcl	Memantine Hcl	135	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	133	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	128	18
Pantoprazole Sodium	Pantoprazole Sodium	119	12
Lactulose	Lactulose	113	12
Chlorthalidone	Chlorthalidone	112	suppressed
Lisinopril	Lisinopril	106	suppressed
Citalopram Hbr	Citalopram Hydrobromide	104	suppressed
Tradjenta	Linagliptin	100	suppressed
Furosemide	Furosemide	99	13
Spironolactone	Spironolactone	91	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	86	suppressed
Torsemide	Torsemide	84	11
Finasteride	Finasteride	79	suppressed
Alendronate Sodium	Alendronate Sodium	78	suppressed
Levetiracetam	Levetiracetam	76	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	72	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	suppressed
Allopurinol	Allopurinol	70	suppressed
Latanoprost	Latanoprost	68	18
Venlafaxine Hcl Er	Venlafaxine Hcl	67	suppressed
Montelukast Sodium	Montelukast Sodium	63	suppressed
Budesonide	Budesonide	62	suppressed
Carvedilol	Carvedilol	62	suppressed
Olanzapine	Olanzapine	62	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	57	56
Midodrine Hcl	Midodrine Hcl	55	suppressed
Xarelto	Rivaroxaban	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	suppressed
Buspirone Hcl	Buspirone Hcl	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Glipizide	Glipizide	47	suppressed
Risperidone	Risperidone	47	suppressed
Aripiprazole	Aripiprazole	44	suppressed
Methenamine Hippurate	Methenamine Hippurate	44	suppressed
Tramadol Hcl	Tramadol Hcl	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Jardiance	Empagliflozin	37	suppressed
Prednisone	Prednisone	37	suppressed
Bupropion Hcl	Bupropion Hcl	36	suppressed
Famotidine	Famotidine	32	suppressed
Acetylcysteine	Acetylcysteine	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	29	suppressed
Erythromycin	Erythromycin Base	29	suppressed
Anastrozole	Anastrozole	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Baclofen	Baclofen	25	suppressed
Dutasteride	Dutasteride	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Clozapine	Clozapine	21	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Permethrin	Permethrin	21	21
Clonazepam	Clonazepam	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Ursodiol	Ursodiol	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	11
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Repatha Syringe	Evolocumab	16	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levetiracetam Er	Levetiracetam	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Tobradex	Tobramycin/Dexamethasone	13	suppressed
Topiramate	Topiramate	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Colchicine	Colchicine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Bacitracin-Polymyxin	Bacitracin/Polymyxin B Sulfate	11	suppressed
Moxifloxacin	Moxifloxacin Hcl	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error